Division of Basic Medical Research Research Program on Hepatitis
Outline
Key Fields | Innovative Drug Discovery and Development Project, Health and Clinical Data Project, Basic Medical Research Project |
---|---|
R&D phase | Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Research, None |
Contact |
|
This program aims to significantly improve the treatment of hepatitis by comprehensively promoting basic and clinical research on hepatitis in partnership with national and local government. This program includes the following two sub-programs:
- i. Program for Basic and Clinical Research on Hepatitis
- This program aims to improve the methods for hepatitis prevention, diagnosis, and treatment. This program also facilitates basic and clinical research that leads to the development of pharmaceuticals and medical devices necessary for treatment.
- ii. Program on the Innovative Development and Application of New Drugs for Hepatitis B
- This program aims to develop revolutionary therapeutic agents for hepatitis B. It comprehensively promotes clinical research, which results in drug discovery and its practical applications on the basis of fundamental research.
List of Research Projects
- FY2022 List of Projects
- FY2021 List of Projects
- FY2020 List of Projects
- FY2019 List of Projects
- FY2018 List of Projects
Management and Evaluation Framework
- PS (Program Supervisor)
-
- HAYASHI Norio, Director General, Japan Organization of Occupational Health and Safety,Kansai Rosai Hospital
- PO (Program Officer)
-
- IMAZEKI Fumio, Head of Safety and Health Organization, Chiba University
- ESUMI Mariko, Visiting Professor, Nihon University
- SAIGO Ken-ichi, Division Head, Chiba Hospital, Japan Community Healthcare Organization
- TAKEBE Yutaka, Visiting Professor, National Center for AIDS/STD Control and Prevention, China
- NAKAGAWA Mina, Associate Professor, Tokyo Medical and Dental University
- HANAOKA Fumio, Director-General, National Institute of Genetics
Last updated 11/08/22